Literature DB >> 12736812

Renal biopsy 2-9 years after Henoch Schönlein purpura.

Carmen Algoet1, Willem Proesmans.   

Abstract

Twelve children and adolescents with classical Henoch-Schönlein purpura (HSP) underwent renal biopsy 2-9 years later. The clinical course was favorable in 10 of the patients who received only supportive treatment. Two patients with a prolonged course, characterized by marked hematuria and proteinuria, were given steroids and azathioprine first and mycophenolate mofetil later. At the time of biopsy, 4 patients did not have any urinary abnormalities, 6 had hematuria and/or mild proteinuria, and 2 had proteinuria >1 g/24 h. Renal histology showed mild lesions on light microscopy. Immunohistochemistry disclosed mesangial IgA in 8 of the 12 patients. In percentages, this is a proportion of 66.6 with 95% exact confidence limits of 34.9-90.1. In this small series of selected former HSP patients, the majority had IgA nephropathy years after the initial vasculitis episode. This indicates that some patients with apparently completely healed HSP have a chronic glomerular condition that possibly means protracted disease and certainly indicates the need for careful follow-up.

Entities:  

Mesh:

Year:  2003        PMID: 12736812     DOI: 10.1007/s00467-003-1132-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  8 in total

1.  [Henoch-Schoenlein purpura-nephritis followed by IgA-nephritis in 3 children].

Authors:  M R Lilien; R A Donckerwolcke; T M Vroom
Journal:  Ned Tijdschr Geneeskd       Date:  1996-02-10

Review 2.  What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?

Authors:  J C Davin; I J Ten Berge; J J Weening
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

Review 3.  Henoch-Schönlein purpura nephritis: an update.

Authors:  J C Davin; J J Weening
Journal:  Eur J Pediatr       Date:  2001-12       Impact factor: 3.183

4.  ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.

Authors:  K T Woo; Y K Lau; K S Wong; G S Chiang
Journal:  Kidney Int       Date:  2000-12       Impact factor: 10.612

5.  Clinical outcome of Schönlein-Henoch purpura nephritis in children.

Authors:  K Schärer; R Krmar; U Querfeld; H Ruder; R Waldherr; F Schaefer
Journal:  Pediatr Nephrol       Date:  1999-11       Impact factor: 3.714

6.  The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study.

Authors:  Jaana Ronkainen; Matti Nuutinen; Olli Koskimies
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

7.  Henoch-Schönlein nephritis: long-term prognosis of unselected patients.

Authors:  O Koskimies; S Mir; J Rapola; J Vilska
Journal:  Arch Dis Child       Date:  1981-06       Impact factor: 3.791

8.  Long-term follow-up of childhood Henoch-Schönlein nephritis.

Authors:  A R Goldstein; R H White; R Akuse; C Chantler
Journal:  Lancet       Date:  1992-02-01       Impact factor: 79.321

  8 in total
  9 in total

Review 1.  Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood.

Authors:  Marco Zaffanello; Vassilios Fanos
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

2.  Factors affecting histological regression of crescentic Henoch-Schönlein nephritis in children.

Authors:  Jae Il Shin; Jee Min Park; Ji Hong Kim; Jae Seung Lee; Hyeon Joo Jeong
Journal:  Pediatr Nephrol       Date:  2005-11-04       Impact factor: 3.714

3.  Clinical outcome in children with Henoch-Schönlein nephritis.

Authors:  Sevgi Mir; Onder Yavascan; Fatma Mutlubas; Betul Yeniay; Ferah Sonmez
Journal:  Pediatr Nephrol       Date:  2006-09-21       Impact factor: 3.714

4.  Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial.

Authors:  Outi Jauhola; Jaana Ronkainen; Helena Autio-Harmainen; Olli Koskimies; Marja Ala-Houhala; Pekka Arikoski; Tuula Hölttä; Timo Jahnukainen; Jukka Rajantie; Timo Ormälä; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2011-05-28       Impact factor: 3.714

Review 5.  The pathogenesis and treatment of pediatric Henoch-Schönlein purpura nephritis.

Authors:  Yukihiko Kawasaki
Journal:  Clin Exp Nephrol       Date:  2011-06-23       Impact factor: 2.801

6.  Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome.

Authors:  Zhihui Li; Cuirong Duan; Jinhua He; Tianhui Wu; Mai Xun; Yi Zhang; Yan Yin
Journal:  Pediatr Nephrol       Date:  2009-12-02       Impact factor: 3.714

Review 7.  Henoch-Schönlein purpura nephritis.

Authors:  Martin Pohl
Journal:  Pediatr Nephrol       Date:  2014-04-15       Impact factor: 3.714

8.  Presentation of pediatric Henoch-Schönlein purpura nephritis changes with age and renal histology depends on biopsy timing.

Authors:  Imke Hennies; Charlotte Gimpel; Jutta Gellermann; Kristina Möller; Brigitte Mayer; Katalin Dittrich; Anja K Büscher; Matthias Hansen; Wiebke Aulbert; Elke Wühl; Richard Nissel; Gessa Schalk; Lutz T Weber; Michael Pohl; Simone Wygoda; Rolf Beetz; Günter Klaus; Henry Fehrenbach; Sabine König; Hagen Staude; Ortraud Beringer; Martin Bald; Ulrike Walden; Christian von Schnakenburg; Gunhard Bertram; Michael Wallot; Karsten Häffner; Thorsten Wiech; Peter F Hoyer; Martin Pohl
Journal:  Pediatr Nephrol       Date:  2017-10-05       Impact factor: 3.714

Review 9.  Small vessel vasculitis.

Authors:  Paul Brogan; Despina Eleftheriou; Michael Dillon
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.